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Motivation: The 14-3-3 family of phosphoprotein-binding proteins 
regulate many cellular processes by docking onto pairs of phos-
phorylated Ser and Thr residues in a constellation of intracellular 
targets. Therefore, there is a pressing need to develop new predic-
tion methods that use an updated set of 14-3-3-binding motifs for the 
identification of new 14-3-3 targets, and to prioritize the downstream 
analysis of >2000 potential interactors identified in high-throughput 
experiments.  
Results: Here, a comprehensive set of 14-3-3-binding targets from 
the literature was used to develop 14-3-3-binding phosphosite pre-
dictors. Position-specific scoring matrix (PSSM), support vector 
machines (SVM), and artificial neural network (ANN) classification 
methods were trained to discriminate experimentally-determined 14-
3-3-binding motifs from non-binding phosphopeptides. ANN, PSSM 
and SVM methods showed best performance for a motif window 
spanning from -6 to +4 around the binding phosphosite, achieving 
Matthews correlation coefficient of up to 0.60. Blind prediction 
showed that all three methods outperform two popular 14-3-3-
binding site predictors, Scansite and ELM. The new methods were 
used for prediction of 14-3-3-binding phosphosites in the human 
proteome. Experimental analysis of high-scoring predictions in the 
FAM122A and FAM122B proteins confirms the predictions and sug-
gests the new 14-3-3-predictors will be generally useful.  
Availability: A standalone prediction webserver is available at 
http://www.compbio.dundee.ac.uk/1433pred. Human candidate 14-
3-3-binding phosphosites were integrated in ANIA: ANnotation and 
Integrated Analysis of the 14-3-3 interactome database. 
Contact: cmackintosh@dundee.ac.uk and gjbarton@dundee.ac.uk 
Supplementary information: Supplementary data are available at 
Bioinformatics online. 
 
1 INTRODUCTION  
The 14-3-3 phosphoprotein-binding proteins interact with many 
intracellular targets. Changes in the engagement of 14-3-3s with 
different sets of target phosphoproteins cause coordinated shifts in 
cellular behavior in response to growth factors and other stimuli 
  
*To whom correspondence should be addressed.  
(Mackintosh, 2004; Bridges and Moorhead, 2005; Johnson et al., 
2010, 2011). 14-3-3s are boat-shaped dimers that dock onto specif-
ic pairs of phosphorylated Ser and Thr residues (Obsil and 
Obsilova, 2011). The phosphosite pairs are often located in tandem 
on the same target protein, and are typically >15 amino acid resi-
dues apart to allow engagement with both docking sites in the cen-
tral groove of the 14-3-3 dimer (Yaffe et al., 1997; Yaffe, 2002; 
Zhu et al., 2005). The 14-3-3s also have strong preferences with 
respect to the sequences immediately flanking the phosphorylated 
residues (Yaffe et al., 1997; Yaffe, 2002; Zhu et al., 2005).  
Early analyses of known 14-3-3-binding sites indicated 
R(S)X1,2(pS)X(P) as a 14-3-3-binding motif (Muslin et al., 1996; 
Mackintosh, 2004). Later screening of libraries for phosphopep-
tides that displayed optimal binding to 14-3-3s, identified two con-
sensus 14-3-3-binding motifs, namely Mode I (RSX(pS/T)XP) and 
Mode II (RX(F/Y)X(pS)XP), with subtle preferences and negative 
determinants for the X residues (Yaffe et al., 1997; Yaffe, 2002; 
Obsilová et al., 2008). These sequence motifs served as the basis 
for a position-specific scoring matrix (PSSM) to predict potential 
14-3-3-binding phosphosites in Scansite (Obenauer, 2003). A more 
recent survey showed that most experimentally determined 14-3-3-
binding sites (dubbed gold-standards) conform to mode I motifs, 
having at least one basic residue in the positions -3 to -5, relative to 
the phosphoSer/Thr, and never a +1 proline. However, the proline 
at +2 is found in fewer than 50% of cases, and often the serine in 
the -2 position relative to the 14-3-3-binding phosphosite is a resi-
due that is annotated as phosphorylated (Johnson et al., 2010). 
Additionally, Mode III sites, in which the phosphorylated residue 
is the penultimate residue in the C-terminal tail of a protein target, 
have also been reported (Coblitz et al., 2006; Panni et al., 2011). 
Recently, a further striking pattern was identified in the human 
14-3-3 interactome. The majority of well-defined human 14-3-3-
binding phosphoproteins were discovered to be 2R-ohnologues 
(Tinti et al., 2012). This means that they belong to protein families 
of two to four members that were generated by the two rounds of 
whole-genome duplication (2R-WGD), which marked the evolu-
tionary origins of the vertebrate animals ~500 million years ago 
(Makino and McLysaght, 2010; Huminiecki and Heldin, 2010). 
Most of the new genes were negatively selected and lost. However, 
those that were retained in families of two to four members are 
highly enriched in signalling proteins that bind to 14-3-3s (Tinti et 
al., 2012; Huminiecki and Heldin, 2010). In case studies, protein 
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families were identified whose members share one 14-3-3 binding 
site in common (termed the ‘lynchpin’). Lynchpins also align with 
a serine or threonine residue in the pro-orthologue proteins from 
the pre-2R-WGD invertebrate chordates, Branchiostoma (amphi-
oxus, lancelet) and Ciona (tunicates, sea squirts). In contrast, the 
second sites may differ on different family members, and may be 
phosphorylated by different protein kinases. These findings led to 
the proposal that 14-3-3 dimers may have played a mechanistic 
role in the regulatory divergence of 2R-ohnologue families: The 
lynchpin hypothesis proposes that conservation of one ‘lynchpin’ 
14-3-3-binding site gave the freedom for the second site to change, 
and perhaps become a consensus site for phosphorylation by a 
different protein kinase (Johnson et al., 2011). The resulting pro-
tein families therefore operate as ‘signal multiplexing’ systems that 
are regulated by a wider array of protein kinases than would be 
possible if the function were performed by only a single protein.  
Currently, the Scansite 14-3-3 predictor (Obenauer, 2003) is the 
most commonly used software tool to identify potential 14-3-3-
binding phosphosites. Scansite was trained on peptide-libraries 
derived from a limited number of experimentally-defined 14-3-3-
binding sites, but these training datasets no longer accommodate 
the diversity of known 14-3-3-binding phosphopeptides. Another 
source of information on 14-3-3-binding sites is the ‘eukaryotic 
linear motif’ database ELM (Puntervoll, 2003). ELM uses regular 
expressions and context-based filtering to derive pattern probabili-
ties based on a few dozen Mode I, Mode II and non-consensus 
motifs. 
There are now >2000 phosphoproteins that have been found to 
display affinity for 14-3-3 in high-throughput (HTP) proteomics 
experiments (Pozuelo Rubio et al., 2004; Jin et al., 2004; Nishioka 
et al., 2012). Accordingly, there is a need to extend predictors to 
include 14-3-3 binding sites that do not conform to Mode I binding 
and to test the signal multiplexing hypothesis. A more comprehen-
sive picture of potential 14-3-3 binding sites would help to define 
how the complete 14-3-3-interactome system works. The ANIA 
(ANnotation and Integrated Analysis of the 14-3-3 interactome) 
web-service and database (Tinti et al., 2014) integrates multiple 
datasets on 14-3-3-binding phosphoproteins and provides an up-to-
date gold-standard dataset of experimentally determined 14-3-3-
binding phosphosites of all known Modes. In this paper, three new 
classifiers of 14-3-3-binding sites are described that have been 
trained on the ANIA gold-standard dataset. The new predictors are 
compared with Scansite and ELM, predictions for the human 
phosphoproteome performed and a couple of high-scoring sites 
experimentally tested.  
2 METHODS 
2.1 Data collection and preprocessing 
The human proteome was retrieved from the UniProt database (June 2013 
release) and all Ser/Thr residues located in every protein sequence. A col-
lection of annotated phosphoSer/Thr sites (phosphoproteome) was gathered 
from PhosphoSitePlus (October 2013 release) (Hornbeck et al., 2004).  
A list of 300 experimentally determined 14-3-3-binding phosphosites 
was collected from ANIA (Tinti et al., 2014) and further extended from the 
literature to give 322 gold-standard 14-3-3-binding sites (POS) (Supple-
mentary Table S1). A negative dataset (NEG) (Supplementary Table S2) 
was assembled from the literature cited in Johnson et al. (Johnson et al., 
2010), resulting in 93 phosphosites. To prepare balanced sets of POS and 
NEG examples, 230 additional likely non-binding sites were randomly 
selected from a subset of proteins for which two 14-3-3-binding sites had 
been experimentally defined. Although the likely NEG sites are located in 
14-3-3-binding proteins, these sites are thought unlikely to bind 14-3-3s 
since there is currently no evidence of proteins that bind 14-3-3 through 
multiple pairs of phosphosites. The resulting POS and NEG datasets com-
prised balanced numbers of phosphopeptides that were further processed 
for training of the classifiers.  
To explore motif patterns that are in agreement with the modes of bind-
ing previously proposed, five non-symmetrical motif windows around the 
phosphoSer/Thr site were defined, including: [-3:1], [-4:2], [-5:3], [-6:4], 
and [-7:5]. These motif windows ranged from 4 to 12 residues in width not 
including the central phosphoSer/Thr residue. The peptides in the POS and 
NEG datasets were also filtered for sequence redundancy at a range of 
identity thresholds for all pairwise peptide comparisons. When working 
with small peptides, a single amino acid difference can be critical for de-
termining specificity. Thus, determining redundancy in short peptides is not 
straightforward. In this paper, redundancy is defined by differences of 
1…k/2 amino acids, where k is length of the peptide. Thus, redundancy 
thresholds ranged from a minimum of one residue difference up to half of 
the size of the motif window (equivalent to 50% redundancy level). For 
example: for motif window [-6:4] that comprises 10 residues, five levels of 
redundancy were investigated with a minimum number of differences rang-
ing from one to five. Since the number of redundancy thresholds investi-
gated depends on the size of the motif window in analysis, all combinations 
of windows and redundancy thresholds were tested in model training and 
testing. 
In order to reduce the risk of bias, the resulting pairs of balanced POS 
and NEG datasets from different combinations of motif windows and re-
dundancy thresholds were further split into two independent training and 
testing subsets. This gave 240 (75%) and 78 (25%) peptides for training 
and testing respectively. After selecting the best overall models in training 
and testing, final methods were trained using the full non-redundant train-
ing and testing subsets, comprising 318 POS and 318 NEG peptide exam-
ples in total (100%) (Supplementary Table S1 and S2). An additional inde-
pendent and ‘blind’ test dataset (BLIND) comprising 38 experimentally-
defined 14-3-3-binding sites was collected from the literature (Supplemen-
tary Table S3). Following the same strategy used for preparing the training 
datasets, 32 likely non-binding phosphosites were selected as BLIND nega-
tives (Supplementary Table S4).  
2.2 Classification methods 
2.2.1. Artificial neural network (ANN) 
ANN models were trained using the R package RSNNS (Bergmeir and 
Benítez, 2012) and the Stuttgart Neural Network Simulator (SNNS; 
http://www.ra.cs.uni-tuebingen.de/SNNS). For ANN training, each of the 
20 different amino acids was encoded as a binary vector of length 20. For 
example: Ala was encoded as [1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0], 
whereas Arg was encoded as [0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]. This 
pattern was followed for all 20 amino acids while gaps or other ambiguous 
amino acids were encoded as [0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]. Ac-
cordingly, phosphopeptides of length k (4 ≤ k ≤ 12) were encoded by vec-
tors of length 20k. The final ANN model had 20 input nodes, a single hid-
den layer with 20 nodes, and one output layer with one output node. Train-
ing was performed by the backpropagation algorithm with momentum term 
(‘Backpropmomentum’), learning parameter η = 0.2, and momentum term 
µ  = 0.05. 
2.2.2. Position-specific scoring matrix (PSSM) 
PSSMs were implemented in Python (http://www.python.org) and assem-
bled by adapting the procedure described by Ferrari and colleagues (Ferrari 
et al., 2011). Amino acid frequency matrices were derived from POS and 
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NEG datasets and from a background (BGD) dataset, made up of all pep-
tides that have annotated phosphoSer/Thr sites (phosphoproteome). For 
each motif window of length k of the alignment (4 ≤ k ≤ 12); a PSSM was 
assembled with 21 rows (20 amino acids plus gaps or ambiguous (X), AA = 
(A, R, N, D, C, Q, E, G, H, I, L, K, M, F, P, S, T, W, Y, V, X)) and k col-
umns, where the values represent the frequency of amino acid i {i ∈ AA} at 
the jth position {j = 1…k} in the multiple alignment of all peptides. Equa-
tion 1 defines the final score S(p) assigned to each queried phosphopeptide 
p which is calculated by adding up the scores for all the positions, where  
S( p) = POSi , j − NEGi , j
BGDi , jj
k
∑       (1) 
POSi,j, NEGi,j, and BGDi,j are the frequency values for amino acid i at posi-
tion j, in the POS, NEG and BGD matrices, respectively. 
2.2.3. Support vector machines (SVM) 
SVM models were trained and parameterized using the Python module 
PyML (http://pyml.sourceforge.net), which contains a set of non-linear 
kernels specifically developed for training and classification of biological 
sequences (Ben-Hur et al., 2008). The final SVM model employed the 
weighed-degree kernel (Sonnenburg et al., 2005), with soft margin constant 
C, which specifies the degree of separation between the two training classes 
of support vectors in the hyperplane, was set to one. Lastly, the cosine 
kernel was applied to normalize the kernel values.  
2.3 Feature selection for the ANN models 
Two independent alphabet reduction systems were tried. Both methods 
grouped the 20 amino acids in 10 classes according their physicochemical 
properties, and were encoded as an orthogonal 10-length binary (Li et al., 
2003; Livingstone and Barton, 1993). 
Further features were also explored as inputs to the ANN model. Protein 
secondary structure predictions and solvent accessibility were computed by 
Jpred (Cole et al., 2008), which provides predictions of α-helix, β-strand, 
random coil, and solvent accessible or buried. In addition to the 20-length 
binary vector of amino acid encodings, every residue position including the 
central Ser/Thr was encoded as a 5-length binary vector or alternatively 
encoded as a vector of raw Jpred prediction scores [0.0:1.0], resulting in a 
vector of length 20k + 5(k + 1). Similarly, three methods for predicting 
natively unstructured/disordered regions in proteins (Dosztányi et al., 2005; 
Linding, 2003; Linding et al., 2003) were computed using the JABAWS 
package (Troshin et al., 2011). Peptide motifs were classified as disordered 
or structured by four methods, and were encoded as a binary vector of 
length 2, which resulted in an encoding vector of length 20k + 2(4). IUPred 
prediction scores ≥0.5 were used to define disordered regions, whereas for 
GlobPlot, the Dydx algorithm with a threshold of ≥0.0 was used. Regions 
predicted by both DisEMBL algorithms: HOTLOOPS and REM465; were 
considered for disorder classification. 
2.4 Evaluation methods 
The performance of each classifier was evaluated by Jackknife (leave-one-
out cross-validation) on the training and testing data, before a final test on 
the BLIND dataset. The performance of each method was assessed by re-
ceiver operating characteristic (ROC) curves which were plotted at various 
thresholds (Fawcett, 2004). The area under the ROC curve (AUC) (Sonego 
et al., 2008) was used as the primary performance measure. Additional 
standard metrics were calculated for each method including: sensitivity 
(SN, equivalent to recall) (Eq. 1), specificity (SP) (Eq. 2), positive predic-
tive value (PPV, equivalent to precision) (Eq. 3), accuracy (ACC) (Eq. 4), 
and Matthews correlation coefficient (MCC) (Eq. 5), where TP, FP, TN, 
FN denote the number of true positives, false positives, true negatives and 
false negatives, respectively. 
          SN = TP
TP + FN
                                                                          (1)         
          SP = TN
TN + FP
                                                                           (2)  
       PPV = TP
TP + FP
                                                                       (3)  
          
ACC = TP +TN(TP +TN + FP + FN )                                                  (4) 
        MCC = TP ×TN − FP ×FN
(TP + FP)(TP + FN )(TN + FP)(TN + FN )
        (5) 
 
Evaluation and statistical analysis was performed in the R statistical lan-
guage (http://www.r-project.org) and ROCR package (Sing et al., 2005). 
Sample correlation analysis was performed by the Pearson correlation 
coefficient (r). For two-sample paired tests, the Wilcoxon-Mann-Whitney 
test and the Student’s t-test were performed. The null hypothesis was in-
ferred at a 95% level of confidence. 
2.5 Biochemical methods 
The cDNA encoding human FAM122A (Q96E09) was amplified from 
IMAGE consortium EST clone 6182641(coding for NM_138333.3 CDS) 
and FAM122B (Q7Z309) was from IMAGE consortium EST clone 
3841054 (coding for NM_145284.3 CDS). Three isoforms of FAM122C 
(Q6P4D5) were cloned: NP_620174.1 amplified from IMAGE clone 
4699951 (152 residues); Q6P4D5.1, amplified from IMAGE clone 
5229041 (195 residues); and AAH65225.1, amplified from IMAGE clone 
5724414 (96 residues). cDNAs were cloned as BamHI/NotI inserts into the 
multiple cloning site of pcDNA5 FRT/TO that adds a C-terminal GFP tag 
to the expressed protein. Mutants were made using PCR mutagenesis and 
DNA sequencing was performed by The Sequencing Service, University of 
Dundee (www.dnaseq.co.uk). Plasmids are available from the MRC-PPU 
reagents website (mrcppureagents.dundee.ac.uk).  
Proteins were isolated using GFP-Trap® (ChromoTek) from lysates of 
transfected human embryonic kidney 293 (HEK293) cells, using a lysis 
buffer that preserves their in vivo phosphorylation status. The isolated 
proteins were tested for retention of co-purified endogenous 14-3-3 pro-
teins (K19 pan-14-3-3 antibody, Santa Cruz Biotech), and for their ability 
to bind directly to 14-3-3s in Far-Western overlays, as in X(ANIA). Where 
indicated, isolated proteins were dephosphorylated, or not, as in X,(ANIA) 
prior to analysis of their interaction with 14-3-3. 
3 RESULTS AND DISCUSSION 
3.1 Development and evaluation of 14-3-3 classifiers  
Three new 14-3-3 classifiers were developed in this work. Data 
preprocessing was performed so that all combinations of motif 
window length and redundancy thresholds were evaluated in model 
training and model testing. The comparison of the area under the 
ROC curve (AUC) scores by Jackknife for the resulting classifiers 
showed that the highest performance was achieved at a redundancy 
threshold of at least one residue difference (sequence identi-
ty <90%), for a motif region spanning from -6 to 4. A motif win-
dow [-6:4] agrees with observed 14-3-3-binding modes (Johnson et 
al., 2010) and performed better in this study than [-7:7] which has 
been previously selected for this kind of classification task 
(Obenauer, 2003; Miller et al., 2008)).  
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 As shown in Fig. 1A, all three methods performed similarly well 
in model training and model testing, with AUC scores ranging 
from 0.84 (for the SVM in model training) to 0.87 (for PSSM and 
SVM in model testing). Fig. 1B shows the performance of the final 
models trained using balanced and non-redundant POS and NEG 
datasets (318 POS and 318 NEG peptide examples), generated by 
combining non-redundant training and testing sub-sets. ANN and 
PSSM showed an AUC of 0.86, whereas the SVM showed an 
AUC of 0.85. Although globally the performance of the final 
methods is not significantly different, the ANN presented the high-
est Matthews correlation coefficient (MCC) score of 0.59±0.01 
(SD), accuracy (ACC) of 79.6±0.6% and a positive predictive val-
ue (PPV) of 79.8±1.6%.  
Since phosphorylated Ser/Thr usually lie at the protein surfaces 
enabling kinase/phosphatase activity, as well as regulation by the 
14-3-3s (Vandermarliere and Martens, 2013), additional features 
such as secondary structure, solvent accessibility, and protein dis-
order, were tested to see their effect on performance, as was fea-
ture-selection by amino acid alphabet reduction. Although these 
approaches have proved useful in a number of classification tasks 
(for example (McDowall et al., 2009; Aytuna et al., 2005)), here 
they added complexity, but did not give a significant improvement 
in the performance of the methods developed here (data not 
shown).  
3.2  Comparison with other predictors 
The performance of the new classification methods developed here 
was compared with Scansite (Obenauer, 2003) and ELM 
(Puntervoll, 2003), using an additional dataset (the BLIND set) that 
was not used for training the methods. The BLIND dataset com-
prises 38 experimentally-defined 14-3-3-binding phosphopeptides 
and 32 non-14-3-3-binding sites. Raw Scansite prediction scores 
were obtained by querying Netphorest (Miller et al., 2008), that 
fully implements the original Scansite PSSM. Categorical classifi-
cation scores were also obtained for each BLIND phosphoprotein, 
from the Scansite2 (Obenauer, 2003), Scansite3 (unpublished work 
by Tobias Ehrenberger, 2012), and ELM webservers (Dinkel et al., 
2013). Scansite2 provides prediction scores based on 14-3-3 Mode 
I motifs that fall into three stringency levels: high, medium, and 
low. Scansite3, a Java implementation of Scansite2, enables search 
for a fourth stringency level: minimum. ELM uses context-based 
filtering and text-mining to improve the accuracy of assigned pat-
tern-matching probabilities based on Mode I and Mode II 14-3-3-
binding as well as non-consensus 14-3-3-binding. Overall, any 
phosphoSer/Thr site for which a prediction score was provided (at 
a particular stringency level, in the case of Scansite), was consid-
ered to be classified as 14-3-3-binding. All the remaining sites 
were classified as non-14-3-3-binding. Although other methods 
exist to predict 14-3-3 binding sites (Chan et al., 2011; Panni et al., 
2011) no software or pre-computed predictions were available for 
comparison to the methods developed here. 
As shown in Table 1, all three methods developed here showed 
higher MCC scores (up to 0.60 for ANN and PSSM), when com-
pared Netphorest Scansite, Scansite2 and Scansite3 at different 
stringency levels, and ELM (up to 0.52 for Scansite2 low and 
ELM). Indeed, the new methods present the best accuracy (ACC of 
80.0% for the ANN and 78.6% for PSSM and SVM), compared to 
 
Fig. 1. Performance of the classifiers tested by Jackknife. ROC curves and 
the area under the ROC curves (AUC) scores for: (A) model training (bold 
line) and model testing (dotted line); (B) final models; (C) comparison to 
Netphorest Scansite on the BLIND dataset. ANN, PSSM and SVM models 
were trained at the redundancy level of at least one residue difference and 
for a [-6:4] motif window. 
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accuracies of the other predictors, which are generally lower than 
75.7% (obtained for Scansite2 low). The performance scores of the  
new methods agree with the performance observed in model train-
ing and testing (Fig. 1). However, the PPV observed for the BLIND 
dataset is higher (from 79.8% for the final models compared to 
≥85.3% PPV for the BLIND dataset), which might be an outcome 
of the unbalanced composition of the BLIND dataset. A consensus 
predictor achieved 0.61 MCC and 80.0% ACC by averaging the 
scores from the three methods. Both Scansite2 and Scansite3 high 
stringency showed 100% PPV and 100% specificity (SP). This 
results from the fact that both methods incorrectly classify most 
sites as non-14-3-3 binding and give small numbers of TP and FP 
(zero FP in this particular case) but high FN. In terms of sensitivity 
(SN), the best method was Scansite3 minimum with 84.2% SN, 
compared to the ANN that showed 76.3% SN. Here, Scansite3 
minimum correctly predicted 32 out of 38 POS examples, whereas 
the ANN correctly predicted 29/38. Although Scansite predictors 
show higher SN and SP, the new predictors show a better balance 
between these two metrics, which leads to superior ACC and MCC 
scores.  
Two-sample sequence analysis of the final POS and NEG da-
tasets revealed that Mode I is indeed the most common, accounting 
for ~46% enrichment of Arg at position -3, ~31% enrichment of 
Pro at +2 position. Additionally, poorer enrichment of Ser and Leu 
at positions -2 and +1, respectively, as well as depletion of Pro at 
+1, is also observed. A similar profile is observed for the BLIND 
dataset which might explain why Scansite low and minimum cor-
rectly classifies POS examples equally well as the consensus pre-
dictor. However, non-consensus binding motifs are better covered 
by the methods introduced here since the consensus motifs I and II 
represent less than 30% of POS in both training and blind datasets. 
The correlation between the consensus predictor and Netphorest 
Scansite scores, for prediction of 14-3-3-binding phosphopeptides 
in the human proteome (section 3.3), is only r = 0.65 (p < 0.001), 
indicating that a fair number of peptides produce discordant pre-
dictions by Scansite and the methods developed here. 
Overall, based on the performance measures and benchmark re-
sults shown in Table 1 and Fig. 1C, all methods introduced in this 
study outperform the previous predictors with Scansite2 low and 
ELM the closest rivals. The Consensus predictor is significantly 
better than all the Scansite predictors and ELM, based on the MCC 
scores obtained for the BLIND dataset (p<0.05). Since the exact 
peptide datasets used for training Scansite are not known, it is like-
ly that the real performance of Scansite will be lower, as some of 
the tested examples could have been used for its training. Similar-
ly, ELM adds literature annotation for known 14-3-3-binding 
phosphosites when available, so its prediction performance is per-
haps over-optimistic. In fact, ~60% (15/24) TP were annotated 
from the literature, making this benchmark evaluation moderately 
biased in favour of ELM. Intriguingly, Scansite2 and Scansite3 
presented some classification differences at high and low stringen-
cy levels. Whether this difference is the result of the new imple-
mentation of Scansite3, potentially setting new underlying strin-
gency thresholds, or due to the addition of a minimum stringency 
level is not clear.  
3.3 Prediction and experimental testing of 14-3-3-
binding phosphosites in the human proteome 
 All 1,543,965 Ser/Thr residues in the 20,245 proteins of the 
human proteome as released in June 2013, were considered as 
potential 14-3-3 sites and ranked according to the methods devel-
oped here. The consensus classifier predicted a total of 75,891 
potential binding sites in 17,214 proteins. This corresponds to 
4.9% of all Ser/Thr sites with an average of 4 sites per protein. 
Considering only the set of 117,640 proteins for which phos-
Table 1. Comparison of the predictors developed in this study with Scansite and ELM, for an external BLIND dataset comprising 38 literature-curated 
14-3-3-binding sites and 32 non-binding sites. The table is sorted by MCC score. 
Predictor TP FP TN FN SN (%) SP (%) PPV (%) ACC (%) MCC * 
Consensus a, b 28 4 28 10 73.7 87.5 87.5 80.0 0.61 
ANN a 29 5 27 9 76.3 84.4 85.3 80.0 0.60 
PSSM a 26 3 29 12 68.4 90.6 89.7 78.6 0.60 
SVM a 27 4 28 11 71.1 87.5 87.1 78.6 0.59 
Netphorest Scansite c 28 7 25 10 73.7 78.1 80.0 75.7 0.52 
Scansite2 low d 28 7 25 10 73.7 78.1 80.0 75.7 0.52 
ELM d 24 4 28 14 63.2 87.5 85.7 74.3 0.52 
Scansite3 low d 27 7 25 11 71.1 78.1 79.4 74.3 0.49 
Scansite3 minimum d 32 13 19 6 84.2 59.4 71.1 72.9 0.45 
Scansite2 high d 12 0 32 26 31.6 100.0 100.0 62.9 0.42 
Scansite2 medium d 17 4 28 21 44.7 87.5 81.0 64.3 0.35 
Scansite3 high d 9 0 32 29 23.7 100.0 100.0 58.6 0.35 
Scansite3 medium d 17 4 28 21 44.7 87.5 81.0 64.3 0.35 
 a The results shown were calculated based on optimal thresholds derived from accuracy/cut-off plots for the final models. The cut-offs are 0.55, 0.80, 0.25 and 0.50, for 
ANN, PSSM, SVN and Consensus, respectively. b The consensus predictor averages the scores obtained by the three methods: ANN, PSSM and SVM. c Scansite PSSM 
prediction scores were obtained by querying Netphorest. An optimal cut-off of 0.15 resulted in the balanced performance observed for Scansite2 low; d Based on categorical 
classification of the queried phosphoproteins. * The significance level of each method’s MCC score was assessed against the MCC score of the Consensus predictor by 
computing a distribution of MCC scores for 100 bootstrap replicates with replacement, randomly selecting examples from the BLIND dataset. Underlined MCC scores 
indicate that the method is significantly worse than the consensus predictor (p < 0.05) whereas double underline indicates high significance (p < 0.001). 
SN – Sensitivity; SP – Specificity; PPV – Positive predictive value; NPV – Negative predictive value; ACC – Accuracy; MCC – Matthews correlation coefficient. 
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phoSer/Thr sites have already been annotated, the number of pre-
dicted sites falls to 10,881 in 5,483 proteins. This corresponds to 
9.2% of all Ser/Thr sites in the phosphoproteome and an average 2 
candidate phosphosites per protein, which reduces the potential 
number of FP, since proteins known to be phosphorylated poten-
tially bind to 14-3-3 dimers. This approach makes it more amena-
ble for prioritizing experimental investigation. As shown below, 
two high-ranking ANN predictions were further tested by experi-
ment. 
Table 2 shows the top 20 high-scoring candidates sites predicted 
by the three methods on the phosphoproteome. Predicted proteins 
include: Sperm-specific antigen 2 (3rd); Sorbin and SH3 domain-
containing protein 1 (5th); Negative elongation factor E (6th); E3 
ubiquitin-protein ligase HUWE1 (17th); E3 ubiquitin-protein ligase 
UBR4 (18th); and Centrosomal protein of 170 kDa (19th): all of 
which had been previously detected in 14-3-3-binding capture 
experiments (Tinti et al., 2014; Wang et al., 2011), but whose 14-
3-3-binding sites remained elusive. High-scoring predictions by the 
consensus predictor support that these proteins partner with 14-3-
3s, however further experiments have to be performed to validate 
these candidate binding-sites.  
Two of the predicted sites, ranked at 2nd and 11th with consensus 
scores of 1.88 and 1.67, are for Family with sequence similarity 
122A and 122B (FAM122A and FAM122B). FAM122 is a family 
of three uncharacterized proteins (A, B and C). FAM122A and 
FAM122B is a pair of 2R-ohnologues, while FAM122C evolved 
by tandem duplication of FAM122B in mammals (adjacent genes 
at Xq26.3). Such tandem duplication of 2R-ohnologues is rare 
(Makino and McLysaght, 2010).  
Consistent with the 14-3-3-Pred results (Table 2), all three 
FAM122 family members displayed phosphorylation-dependent 
binding to 14-3-3 proteins when isolated from transfected cells 
(Fig. 2A). The binding of 14-3-3 to FAM122A was abolished by 
its dephosphorylation (Fig. 2B) and by substitution of Ser37 of 
FAM122A with alanine (Fig. 2C). Although phosphoSer62 and 
phosphoThr64 of FAM122A also had relatively high 14-3-3-Pred 
scores (0.614 and 1.076 respectively), mutation of these residues 
did not affect 14-3-3 binding to FAM122A isolated from cells 
cultured in standard serum-containing medium (Fig. 2C). Howev-
er, in the absence of Ser37, stimulating cells with the adenylate 
cyclase activator forskolin caused a marked increase in 14-3-3 
binding to FAM122A, which was abolished when Ser62 was also 
mutated to alanine and when cells were pre-treated with H89, 
which is a non-specific cAMP-dependent protein kinase (PKA) 
inhibitor (Fig. 2D). These data indicate that a 14-3-3 dimer binds 
to both phosphoSer37 and phosphoSer62 on FAM122A, the latter 
likely phosphorylated by PKA. Similar experiments showed that 
14-3-3 binds to phosphoSer25 and forskolin-regulated phos-
phoSer50 of FAM122B, and to phosphoSer29 (ILRRVNSAPLI)  
Table 2. Top 20 high scoring predictions and their respective scores. Proteins that have shown affinity to 14-3-3 in high-throughput (HTP) experi-
ments and 2R-ohnologue members were identified by querying ANIA. FAM122A and FAM122B were experimentally verified to bind 14-3-3 in this 
study.   
Rank Protein Description Site Motif Consensus a 
1 PPP1R3G Protein phosphatase 1 regulatory subunit 3G 86 CRARSFSLPAD 1.97 
2 FAM122A b, c Family with sequence similarity 122A 37 GLRRSNSAPLI 1.88 
3 SSFA2 b Sperm-specific antigen 2 739 PLRRSQSLPTT 1.87 
4 ALOX12 c Arachidonate 12-lipoxygenase, 12S-type 246 LLRRSTSLPSR 1.83 
5 SORBS2 b Sorbin and SH3 domain-containing protein 2 259 FRKRRKSEPAV 1.77 
6 NELFE b Negative elongation factor E 251 PFRRSDSFPER 1.75 
7 ANKRD63 Ankyrin repeat domain-containing protein 63 332 GLRRRSTAPDI 1.74 
8 SECISBP2L c Selenocysteine insertion sequence-binding protein 2-like 251 GRRRRASHPTA 1.72 
9 FAM13A c Family with sequence similarity 13A 741 MRQRSNTLPKS 1.72 
10 FAM189A2 c Family with sequence similarity 189A2 275 LRTRSKSDPVL 1.71 
11 FAM122B b, c Family with sequence similarity 122B 25 TLRRSSSAPLI 1.67 
12 TRAK2 c Trafficking kinesin-binding protein 2 420 TRGRSISFPAL 1.67 
13 CEP57 c Centrosomal protein of 57 kDa 55 DLRRSPSKPTL 1.66 
14 GOLGA5 Golgin subfamily A member 5 116 FVRRKKSEPDD 1.66 
15 CISD2 c CDGSH iron-sulfur domain-containing protein 2 106 RCWRSKTFPAC 1.66 
16 TBC1D22A c TBC1 domain family member 22A 167 PLQRSQSLPHS 1.65 
17 HUWE1 b E3 ubiquitin-protein ligase HUWE1 649 MRRRRSSDPLG 1.65 
18 UBR4 b E3 ubiquitin-protein ligase UBR4 2715 NKRRHVTLPSS 1.62 
19 CEP170 b Centrosomal protein of 170 kDa 644 GERRRRTLPQL 1.60 
20 TMEM40 Transmembrane protein 40 137 GLRRRGSDPAS 1.59 
a The consensus predictor averages the scores obtained by the three methods: ANN, PSSM and SVM. b Proteins that have shown affinity to 14-3-3 in HTP experiments;  
c




of FAM122C. Thus, this is an example of a 2R-ohnologue family 
for which protein members share a conserved 14-3-3-binding 
‘lynchpin’. In fact, half of the top 20 candidate proteins (10/20) 
belong to 2R-ohnologue families.  
The benchmark results for the BLIND dataset, as well as predic-
tion of 14-3-3-binding sites in the human proteome and the analy-
sis of top high-scoring predictions, suggests the new classifiers 
developed in this study will be generally useful for identifying 
potential 14-3-3 sites. Although the methods developed here were 
not specifically developed to predict pairs of 14-3-3-binding sites 
due the limited set of proteins for which two binding sites are 
known, the example of the FAM122 2R-ohnologue family illus-
trates its use to investigate both primary and secondary 14-3-3-
binding phosphosites.  
A standalone web-server providing a simple yet useful interface 
to the new methods to score potential Ser/Thr centered motifs for 
likelihood of binding 14-3-3 proteins is freely available at 
http://www.compbio.dundee.ac.uk/1433pred. The predictions de-
scribed here were also integrated in the ANIA database. ANIA 
adds a functional layer to the peptide-based predictions, by looking 
for pairs of sites >15 residues apart and by the analysis of sequence 
alignments of 2R-ohnologue families to identify potential lynch-
pins (Tinti et al., 2012, 2014). In addition to the human proteome, 
predictions on proteomes of model organisms, such as Arabidopsis 
thaliana, where several 14-3-3-binding targets have been identified 
(Ferl, 1996; de Boer et al., 2013), will be performed and added to 
ANIA in the future. 
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